Uses Of Galectin-2
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 15, 2008
app pub date -
Mar 24, 2005
filing date -
Mar 26, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Use of galectin-2 or of a nucleic acid coding for galectin-2 or of its complementary strand, or of a nucleic acid hybridizing to such coding nucleic acid or its complementary strand, for the manufacture of a medicament for the treatment or prevention of a patient having a disease with impaired apoptosis of T-cells, macrophages and/or antigen-presenting cells, or for the manufacture of a medicament for the treatment or prevention of organ rejection in a patient having undergone organ transplantation, in particular solid organ transplantation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully